ALL COMPANIES

Develops adipose-derived mesenchymal stem cells (HB-adMSCs) to slow disease progression by supporting cellular repair and regeneration.

Uses bone marrow-derived allogeneic (from other people, not from the patient) mesenchymal stem cells to treat neurodegeneration. The goal is...

NTCell is a cell/tissue therapy utilizing pig choroid plexus cells. These cells are transplanted into the brain to produce neurotrophic...

TED-A9 is a cell/tissue therapy that uses A9 dopaminergic neuron precursor cells to address motor impairment. It aims to replace...

Mitokinin is developing small molecules to increase the activity of PINK, a protein involved in the breakdown of (damaged) mitochondria. ...

This company is developing small molecules to improve the function of mitochondria. 

MT-101-5 is a small molecule that acts as both a mitochondrial enhancer and alpha-synuclein (aSyn) inhibitor. This multi-component therapeutic enhances...

Vutiglabridin (HSG-4112) is a small molecule that functions as a Paraoxonase 2 (PON2) modulator. PON2 is an enzyme involved in...

Ursodiol (UDCA) is a small molecule functioning as a mitochondrial enhancer. Mitochondria are essential for energy production in cells, and...